Cargando…
Bioorthogonal Catalytic Activation of Platinum and Ruthenium Anticancer Complexes by FAD and Flavoproteins
Recent advances in bioorthogonal catalysis promise to deliver new chemical tools for performing chemoselective transformations in complex biological environments. Herein, we report how FAD (flavin adenine dinucleotide), FMN (flavin mononucleotide), and four flavoproteins act as unconventional photoc...
Autores principales: | Alonso‐de Castro, Silvia, Cortajarena, Aitziber L., López‐Gallego, Fernando, Salassa, Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887934/ https://www.ncbi.nlm.nih.gov/pubmed/29359850 http://dx.doi.org/10.1002/anie.201800288 |
Ejemplares similares
-
Riboflavin as a bioorthogonal photocatalyst for the activation of a Pt(IV) prodrug
por: Alonso-de Castro, Silvia, et al.
Publicado: (2017) -
Bioorthogonal Azide–Thioalkyne Cycloaddition Catalyzed by Photoactivatable Ruthenium(II) Complexes
por: Gutiérrez‐González, Alejandro, et al.
Publicado: (2021) -
Metal substrate catalysis in the confined space for platinum drug delivery
por: Velasco-Lozano, Susana, et al.
Publicado: (2021) -
How an assembly factor enhances covalent FAD attachment to the flavoprotein subunit of complex II
por: Maklashina, Elena, et al.
Publicado: (2022) -
Oxidation of the FAD cofactor to the 8-formyl-derivative in human electron-transferring flavoprotein
por: Augustin, Peter, et al.
Publicado: (2018)